Package 70000-0049-1

{"route": ["ORAL"], "spl_id": "1e0b3110-f090-418a-9ade-612f7e8ff90f", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["5QZO15J2Z8"], "rxcui": ["310273"], "spl_set_id": ["78b168f1-846d-4e88-a8ee-845c41c9dcbe"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["LEADER/ CARDINAL HEALTH 110, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (70000-0049-1)  / 25 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "70000-0049-1", "marketing_start_date": "20200404"}], "brand_name": "Famotidine", "product_id": "70000-0049_1e0b3110-f090-418a-9ade-612f7e8ff90f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "70000-0049", "generic_name": "Famotidine", "labeler_name": "LEADER/ CARDINAL HEALTH 110, INC.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "20 mg/1"}], "application_number": "ANDA206531", "marketing_category": "ANDA", "marketing_start_date": "20200404", "listing_expiration_date": "20261231"}